Stability Studies and Release Testing

Coriolis Pharma offers comprehensive GMP and non-GMP analyses for the release and stability testing of biopharmaceutical products – from early development stages through to commercial production. This includes ICH-compliant stability studies under controlled climate and storage conditions to ensure product efficacy, quality, and safety throughout its shelf life . The portfolio is complemented by robust release testing to verify compliance with the Target Product Profile (TPP) and regulatory requirements.